Tyler-Stone Wealth Management’s Anixa Biosciences ANIX Stock Holding History

Tyler-Stone Wealth Management’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$139K	Hold	42,016	–	–	0.02%	327
2025 Q1	$120K	Hold	42,016	–	–	0.02%	315
2024 Q4	$97.5K	Hold	42,016	–	–	0.02%	320
2024 Q3	$132K	Buy	42,016 +21,008	+100%	+$64.6K	0.03%	313
2024 Q2	$46.4K	Hold	21,008	–	–	0.02%	377
2024 Q1	$65.5K	Hold	21,008	–	–	0.03%	335
2023 Q4	$81.5K	Hold	21,008	–	–	0.04%	288
2023 Q3	$69K	Hold	21,008	–	–	0.04%	298
2023 Q2	$67K	Buy	+21,008	New	+$80.9K	0.04%	305
2022 Q4	$89K	Hold	21,008	–	–	0.06%	249
2022 Q3	$103K	Hold	21,008	–	–	0.08%	216
2022 Q2	$64K	Hold	21,008	–	–	0.04%	291
2022 Q1	$58K	Hold	21,008	–	–	0.03%	319
2021 Q4	$62K	Buy	+21,008	New	+$84.9K	0.03%	329

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MWM

Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Tyler-Stone Wealth Management's ANIX Position: Q2 2025 in Review

Tyler-Stone Wealth Management held its Anixa Biosciences (ANIX) position steady in Q2 2025 at 42,016 shares worth $139K. The position accounts for 0.02% of the portfolio, ranked #327.

Tyler-Stone Wealth Management first reported a position in ANIX in Q4 2021 and has held it in 14 quarters since. 66 funds tracked by Wall St. Rank hold ANIX as of Q2 2025.

Tyler-Stone Wealth Management held 42,016 shares of Anixa Biosciences worth $139K as of Q2 2025.
Tyler-Stone Wealth Management left its Anixa Biosciences share count unchanged in Q2 2025.
Anixa Biosciences made up 0.02% of Tyler-Stone Wealth Management's portfolio in Q2 2025, its #327 holding.
Tyler-Stone Wealth Management first reported a position in Anixa Biosciences in Q4 2021 and has held it in 14 quarters since.
66 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2025.

Based on Tyler-Stone Wealth Management's 13F filing for Q2 2025, filed 18 Aug 2025.